- Home
- KLTOW vs ICUCW Comparison
KLTOW vs ICUCW Comparison
Compare KLTOW & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- ICUCW
- Stock Information
- Founded
- KLTOW N/A
- ICUCW N/A
- Country
- KLTOW United States
- ICUCW United States
- Employees
- KLTOW 3
- ICUCW 19
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- KLTOW Health Care
- ICUCW Health Care
- Exchange
- KLTOW Nasdaq
- ICUCW Nasdaq
- Market Cap
- KLTOW N/A
- ICUCW N/A
- IPO Year
- KLTOW 2022
- ICUCW 2021
- Fundamental
- Price
- KLTOW $0.20
- ICUCW $0.03
- Analyst Decision
- KLTOW
- ICUCW
- Analyst Count
- KLTOW 0
- ICUCW 0
- Target Price
- KLTOW N/A
- ICUCW N/A
- AVG Volume (30 Days)
- KLTOW N/A
- ICUCW N/A
- Earning Date
- KLTOW N/A
- ICUCW N/A
- Dividend Yield
- KLTOW N/A
- ICUCW N/A
- EPS Growth
- KLTOW N/A
- ICUCW N/A
- EPS
- KLTOW N/A
- ICUCW N/A
- Revenue
- KLTOW N/A
- ICUCW N/A
- Revenue This Year
- KLTOW N/A
- ICUCW N/A
- Revenue Next Year
- KLTOW N/A
- ICUCW N/A
- P/E Ratio
- KLTOW N/A
- ICUCW N/A
- Revenue Growth
- KLTOW N/A
- ICUCW N/A
- 52 Week Low
- KLTOW N/A
- ICUCW N/A
- 52 Week High
- KLTOW N/A
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- ICUCW N/A
- Support Level
- KLTOW N/A
- ICUCW N/A
- Resistance Level
- KLTOW N/A
- ICUCW N/A
- Average True Range (ATR)
- KLTOW 0.00
- ICUCW 0.00
- MACD
- KLTOW 0.00
- ICUCW 0.00
- Stochastic Oscillator
- KLTOW 0.00
- ICUCW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.